| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/30/2006 | US7052688 At least one strain of hydrogen peroxide-producing lactic acid bacteria, and at least one strain of arginine-utilizing lactic acid bacteria; treatment of infections and inflammatory conditions caused by bacteria, viruses, fungi |
| 05/30/2006 | US7052687 Human recombinant beta-interferon with improved solubility |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | US7052676 Interference with binding chemokines |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2391659C Crystal forms of azithromycin |
| 05/30/2006 | CA2345582C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 05/30/2006 | CA2237594C Fused imidazole derivatives as multidrug resistance modulators |
| 05/30/2006 | CA2165971C Methylphosphonic acid ester, process for preparing the same and its use |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/30/2006 | CA2087525C Adoptive immunotherapy with interleukin-7 |
| 05/30/2006 | CA2005311C Prototype felv isolates for use in disease models and vaccines |
| 05/29/2006 | CA2526684A1 Therapeutic peptides and method |
| 05/26/2006 | WO2006055950A1 Pharmaceutical dry powder formulation on the basis particles comprising multiple active agents |
| 05/26/2006 | WO2006055711A1 Compositions containing aloe vera isolate and a prebiotic and their therapeutic application |
| 05/26/2006 | WO2006055660A2 Method for treating hiv infection through co-administration of tipranavir and uk-427, 857 |
| 05/26/2006 | WO2006055455A1 Method for treating hiv infection through co-administration of tipranavir and darunavir |
| 05/26/2006 | WO2006055359A1 Mixed antibiotic codrugs |
| 05/26/2006 | WO2006054947A1 Novel antimicrobial peptides |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054623A1 Novel pyridonecarboxylic acid derivatives or salts thereof |
| 05/26/2006 | WO2006054396A1 Cyclic isodityrosine derivatives |
| 05/26/2006 | WO2006054135A1 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality |
| 05/26/2006 | WO2006054102A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | WO2006053487A1 The use of vegetable anthraquinone derivatives and vegetable polysaccharides for treating human immunodeficiency virus (hiv) |
| 05/26/2006 | WO2006053485A1 A chimeric mycobacterium tuberculosis gene vaccine and the preparation method thereof |
| 05/26/2006 | WO2006053439A1 Hcv f protein and uses thereof |
| 05/26/2006 | WO2006004660A3 Detection of mutations in a gene associated with resistance to viral infection |
| 05/26/2006 | WO2006004588A3 Immunodynamic complexes and methods for using and preparing such complexes |
| 05/26/2006 | WO2006000922A3 5-aza-7-deazapurine derivatives for treating infections with flaviviridae |
| 05/26/2006 | WO2005100383A3 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 05/26/2006 | WO2005089812A3 Novel antibiotic alternatives |
| 05/26/2006 | CA2588959A1 The use of vegetable anthraquinone derivatives and vegetable polysaccharides for treating human immunodeficiency virus (hiv) |
| 05/26/2006 | CA2588145A1 Novel antimicrobial peptides |
| 05/26/2006 | CA2588034A1 Pyridonecarboxylic acid derivatives or salts thereof |
| 05/26/2006 | CA2587716A1 Hcv f protein and uses thereof |
| 05/26/2006 | CA2587224A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | CA2586231A1 Method for treating hiv infection through co-administration of tipranavir and uk-427, 857 |
| 05/26/2006 | CA2585576A1 Method for treating hiv infection through co-administration of tipranavir and darunavir |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111446 5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor |
| 05/25/2006 | US20060111420 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111309 Chalcomycin derivatives |
| 05/25/2006 | US20060111283 Prevention therapy and prognosis/monitoring in sepsis and septic shock |
| 05/25/2006 | US20060111277 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 05/25/2006 | US20060110463 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 05/25/2006 | US20060110412 Vaccine composition |
| 05/25/2006 | US20060110410 Recombinant toxin fragments |
| 05/25/2006 | US20060110408 Immunological combination compositions and methods |
| 05/25/2006 | US20060110407 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 05/25/2006 | US20060110401 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/25/2006 | US20060110365 Novel bacterium for treatment of disease |
| 05/25/2006 | US20060110363 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/25/2006 | US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 05/24/2006 | EP1659133A2 Human-murine chimeric antibodies against respiratory syncytial virus |
| 05/24/2006 | EP1659132A1 Biologically active bactericidal/permeability-increasing protein fragments |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1659122A1 Crystal of 1-methyl carbapenem compound |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659116A1 Fki-1366 substances and process for producing the same |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658846A1 Substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 05/24/2006 | EP1658845A1 Use of statin or precursor thereof for the treatment of virusinfections |
| 05/24/2006 | EP1658373A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof |
| 05/24/2006 | EP1658367A2 Nucleic and protein sequences from the hxhv virus and uses thereof |
| 05/24/2006 | EP1658305A1 Novel fusidic acid derivatives |
| 05/24/2006 | EP1658302A2 Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c |
| 05/24/2006 | EP1658286A1 N-aryl-2-cyanooxazolidinones and their derivatives |
| 05/24/2006 | EP1658094A1 C1-inh as a drug for treating viruses pathogenic to humans |
| 05/24/2006 | EP1658076A1 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 05/24/2006 | EP1658068A1 Novel cycloalkyl'b! condensed indoles |
| 05/24/2006 | EP1658046A1 Mucoadhesive composition comprising polyacrylate and chemoattractant |
| 05/24/2006 | EP1658034A2 Antibiotic product, use and formulation thereof |
| 05/24/2006 | EP1529050B1 Cephalosporins |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1423418B1 Mutated env gene, mutated env glycoprotein and the use thereof |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1341544B1 Blocking the adsorption of germs in birds |
| 05/24/2006 | EP1337550B1 Hepatitis c tripeptide inhibitors |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1320529B1 Quinoline derivatives as antibacterials |
| 05/24/2006 | EP1257568B1 Novel echinocandin derivatives, preparation method and use thereof as fungicides |
| 05/24/2006 | EP1242102B1 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 05/24/2006 | EP1121382B1 Interferon-beta fusion proteins and uses |
| 05/24/2006 | EP1115397B1 Compositions for mitigating the adverse effects of interleukin-2 |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP1039887B1 Use of aminothiol compounds for the treatment of neuro- and nephro-disorders and therapeutic toxicities |
| 05/24/2006 | EP1019058B1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 05/24/2006 | EP0813539B1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 05/24/2006 | DE19543271B4 Orales pharmazeutisches Präparat An oral pharmaceutical composition |
| 05/24/2006 | DE102004055891A1 Kit for treating cancer, autoimmune diseases, immune deficiency diseases, and as accompanying therapy for bacterial and viral infections, comprises a mixture of snake toxins from at least three different types of snakes |
| 05/24/2006 | DE102004055246A1 Preparation of drug from fungi, useful in immunostimulatory tea for treating viral diseases e.g. flu, comprises cleaning, drying and finely mincing the mycelium of Coriolus versicolor and granulating by using granulation additives |
| 05/24/2006 | DE10128266B4 Verfahren zur Herstellung eines Extrakts aus Zingiber officinale A process for preparing an extract of Zingiber officinale |